Phosphorylation of inner core heptose is a major determinant of bacterial surface lipopolysaccharide recognition by the innate immune protein hSP-D. [PDF]
Williams HM +7 more
europepmc +1 more source
Microbiota Signatures in Early Life and Their Association With Food Allergy: A Systematic Review
ABSTRACT Food allergy (FA) is increasing worldwide, and early life may be a critical window for immune training. We systematically reviewed observational human studies linking early‐life microbiota (infant, maternal, environmental, or extraintestinal) profiled using culture‐based and/or culture‐independent methods (including sequencing‐based approaches)
Eduard Flores Ventura +7 more
wiley +1 more source
<i>In vitro</i> comparative analysis of steamed wood and other lignocellulosic substrates on ruminal fermentation and microbiota. [PDF]
Ito K +10 more
europepmc +1 more source
We assessed whether the maternal perinatal gut microbiome and serum SCFA and cord blood SCFA differ between traditional farming and urban dyads. Women following a farming lifestyle had increased microbial diversity, several differentially abundant bacterial species and functional pathways, and increased circulating SCFA. Overall maternal gut microbiome
Erin C. Davis +7 more
wiley +1 more source
A highly conserved ABC transporter mediates cello-oligosaccharide uptake in the extremely thermophilic, lignocellulolytic bacterium <i>Anaerocellum bescii</i> (f. <i>Caldicellulosiruptor bescii</i>). [PDF]
Tjo H +4 more
europepmc +1 more source
This study examined whether antibiotic use altered the risk of infant allergic disease within a maternal prebiotics supplementation trial. Intrapartum antibiotics were maternal antibiotics administered during childbirth, from the onset of labour or induction until 1‐h before delivery.
Summer V. M. Walker +10 more
wiley +1 more source
Glycoinformatic Profiling of Label-Free Intact Heparan Sulfate Oligosaccharides. [PDF]
Maciej-Hulme ML +14 more
europepmc +1 more source
Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins +6 more
wiley +1 more source

